RSV Vaccine Pregnancy Registry

RecruitingOBSERVATIONAL

Enrollment

2,062

Participants

Timeline

Start Date

June 28, 2024

Primary Completion Date

September 30, 2030

Study Completion Date

September 30, 2030

Conditions

Respiratory Syncytial Virus (RSV)

Interventions

BIOLOGICAL

RSV Vaccine

RSV Vaccine approved for administration to pregnant individuals between 32 weeks, 0 days and 36 weeks, 6 days of gestation

OTHER

Non-exposure to RSV Vaccine

Pregnant individuals who are not exposed to the RSV vaccine

Trial Locations (1)

RECRUITING

PPD, Wilmington